top of page
Group leader

Group Leader

Maria%20Santos_photo_edited.png

Maria M. M. Santos

Santos leads a research team of medicinal chemistry and the ultimate goal of her basic research is the development of general synthetic methods and strategies, and their application to the synthesis of bioactive molecules. Main achievements of Santos’s lab include the discovery of highly potent and selective p53 activators (MDM2/X inhibitors and mutant p53 reactivators), and novel indole-based scaffolds with antimalarial activity, as well as the development of heterocycles that act as NMDA receptor antagonists. 

iMedULisboa
Maria M. M. Santos FFUL
ORCID Maria Santos
Scopus
Ciência Vitae

Senior Researchers

Lab members
XP_edited_edited.png
APF_edited.png
LC_edited.png

Alexandra Paulo

Paulo’s research has evolved throughout the years but being always focused on the discovery of novel chemical tools and drug lead small molecules to translate into innovative therapies. Currently, her research aims to develop selective anticancer and anti-infectious drugs by designing and synthesising small molecules with the capacity to modulate transcription and/or translation of genes involved in regulation of human cancer cells proliferation or in survival of human pathogens (e.g., viruses, malaria parasite and M. tuberculosis). She has participated in several international scientific networks, being presently MC member of COST Action ‘International Nucleome Consortium’.

Ana Paula Francisco

My main research interest along the years has been the development of anticancer agents based in the triazene scaffold. Outside this core interest I have been working on a range of other collaborative and translational projects dedicated mostly to the development or usage of diverse delivery systems that can be associated with drugs and by this improve its pharmacological profile. Other research interests are prodrug chemistry, chemical optimization of bioactive molecules either from synthesis or natural origin and stability and metabolic studies of drugs and prodrugs.

Luís Constantino

Constantino’s research interests are the study of xenobiotic metabolism and the development of new drug delivery systems.  His PhD was in the mechanism of amide metabolism by CYP 450 and later he studied drug metabolism. From that he got interested in prodrugs, specifically in their activation by metabolic reactions and in the prevention of prodrug inactivation. Currently he is studying ester prodrugs for the treatment of tuberculosis and development of new drugs to treat tuberculosis. He is also an expert in patents in the area of pharmacy and has a deep interest in innovation and entrepreneurship.

Alexandra Paulo
ORCID
Scopus
Ciência Vitae
iMed.ULisboa
ORCID
Scopus
Ciência Vitae
iMed.ULisboa
ORCID
Scopus

Lab Members

JP_edited_edited.png

João Pedro Pais
Junior researcher

Bárbara_edited.png

Bárbara Bruni
PhD student

Ciência Vitae
BentoCl%C3%A1udia_edited.png

Cláudia Bento
PhD student

Ciência Vitae
foto_mariana_matheus_edited.png

Mariana Mateus
MSc student

Foto_Oliviero Cini_edited.png

Oliviero Cini
PhD student

Professional profile_edited.png

Elizabeth A. Lopes
PhD student

Ciência Vitae
Foto_Antonio Di Tonno_edited.png

Antonio Di Tonno
MSc student

20220430182345_IMG_0363_edited.png

Miguel Nunes
MSc student

israa%20alakhras%20aljnadi_edited.png

Israa AL-Jnadi
PhD student

Ciência Vitae
Imagem WhatsApp 2023-02-23 às 18.08_edited.png

Ana Francisca Lopes
MSc student

rita_edited.png

Rita Emídio
MSc student

foto_Ricardo_edited.png

Ricardo Ferreira
PhD student

Ciência Vitae
Duarte_edited.png

Duarte Antunes
MSc student

bottom of page